genOway Société anonyme (EPA:ALGEN)
2.290
-0.050 (-2.14%)
At close: Mar 6, 2026
genOway Société anonyme Revenue
genOway Société anonyme had revenue of 12.87M EUR in the half year ending June 30, 2025, with 10.30% growth. This brings the company's revenue in the last twelve months to 27.16M, down -3.28% year-over-year. In the year 2024, genOway Société anonyme had annual revenue of 27.53M with 3.85% growth.
Revenue (ttm)
27.16M
Revenue Growth
-3.28%
P/S Ratio
0.78
Revenue / Employee
183.53K
Employees
148
Market Cap
21.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.53M | 1.02M | 3.85% |
| Dec 31, 2023 | 26.51M | 5.26M | 24.76% |
| Dec 31, 2022 | 21.25M | 1.46M | 7.38% |
| Dec 31, 2021 | 19.79M | 3.47M | 21.30% |
| Dec 31, 2020 | 16.31M | 2.04M | 14.26% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GenSight Biologics | 945.00K |
| Aelis Farma | 2.33M |
| Advicenne | 5.90M |
| NFL Biosciences | 164.00 |
| Poxel | 7.66M |
| Fermentalg | 12.78M |
| Nicox | 3.32M |
| Oncodesign Precision Medicine Société anonyme | 1.74M |